$SOLY News

Last published 4y ago

4y agoSOLYStudy to Evaluate the Safety and Effectiveness of the RAP Device for the Improvement in the Appearance of Cellulite - NCT05199506ClinicalTrials.govAssessing safety, Assessing Efficacy, Assessing Participant Satisfaction
4y agoABBV SOLYAllergan Aesthetics Completes Acquisition of SolitonPR NewswireIRVINE, Calif., Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE:ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ:SOLY). The addition of Soliton and its technology complements Allergan
5y agoHCIC LMNX SOLY STPCMoore Kuehn Encourages LMNX, STPC, HCIC, and SOLY Investors to Contact Law FirmPR NewswireNEW YORK, May 14, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shar
5y agoSOLYSoliton, Inc. /Tx/ to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / May 13, 2021 / Soliton, Inc. /Tx/ (NASDAQ:SOLY) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time. To listen to the event live or access a r
5y agoSOLYSoliton Reports First Quarter 2021 ResultsPR NewswireHOUSTON, May 12, 2021 /PRNewswire/ -- Soliton, Inc., (NASDAQ:SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the first quarter ended March 31, 2021.
5y agoABBV SOLYAllergan Aesthetics to Acquire Soliton, Expanding Body Contouring PortfolioPR NewswireIRVINE, Calif. and HOUSTON, May 10, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE:ABBV) and Soliton (NASDAQ:SOLY) today announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid Ac
5y agoABBV SOLYAllergan Aesthetics to Acquire Soliton, Expanding Body Contouring PortfolioPR NewswireIRVINE, Calif. and HOUSTON, May 10, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE:ABBV) and Soliton (NASDAQ:SOLY) today announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid Ac
5y agoSOLYIntroducing RESONIC™PR NewswireHOUSTON, May 5, 2021 /PRNewswire/ -- Soliton, Inc., (NASDAQ:SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the launch of its highly anticipated Rapid Acoustic Puls
5y agoSOLYSoliton to Report First Quarter 2021 Financial Results on May 13, 2021PR NewswireHOUSTON, May 4, 2021 /PRNewswire/ -- Soliton, Inc., (NASDAQ:SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Company is scheduled to release its first quar
5y agoSOLYSoliton Receives FDA Clearance of Special 510(k)PR NewswireHOUSTON, April 29, 2021 /PRNewswire/ -- Soliton, Inc., (NASDAQ:SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the U.S. Food and Drug Administration ("FDA") clearance of the
5y agoSOLYSoliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual ConferencePR NewswireHOUSTON, April 27, 2021 /PRNewswire/ -- Soliton, Inc., (NASDAQ:SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the 52-week results from its pivotal cellulite trial
5y agoSOLYSoliton Provides Special 510(k) and Commercialization UpdatePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...
5y agoSOLYSoliton to Participate in Three Upcoming Healthcare ConferencesPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...
5y agoSOLYSoliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver FibrosisPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
5y agoSOLYSoliton Reports Fourth Quarter and Full Year 2020 ResultsPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported ...
5y agoSOLYSoliton Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse DevicePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...
5y agoSOLYSoliton Announces RAP Treatment Reduces Effects of Liver Fibrosis by 42% in Animal StudyPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
5y agoSOLYSoliton to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021PR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...
5y agoSOLYSoliton Named Best New Technology Award at the Aesthetic Industry Association Board MeetingPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...
5y agoSOLYSoliton President & CEO Brad Hauser Named as Aesthetic Industry Association Advisory Board MemberPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
5y agoSOLYSoliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in CellulitePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
5y agoSOLYSoliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic ScarsPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...
5y agoSOLYSoliton Appoints Sean J. Shapiro as Vice President of SalesPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...
5y agoSOLYNew patent granted for: Rapid Pulse Electrohydraulic (eh) Shockwave Generator Apparatus and Methods for Medical and Cosmetic TreatmentsUS Patent Applications (USPTO)Apparatuses and methods for electrohydraulic generation of Shockwaves at a rate of between 10 Hz and 5 MHz, and/or that permit a user to view a region of a patient comprising target cells during application of generated Shockwaves to the region. Methods of applying electro-hydraulically generated Shockwaves to target tissues (e.g., for reducing the appearance of tattoos, treatment or reduction of ...
6y agoSOLYSoliton, Inc. (SOLY) CEO Brad Hauser on Q3 2020 Results - Earnings Call TranscriptEarnings Call Transcripts
6y agoSOLYSoliton Reports Third Quarter 2020 ResultsPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported ...
6y agoSOLYSoliton Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executive Officer in Preparation for Commercial LaunchPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Announces Third Quarter 2020 Financial Results and Business Update on Thursday, November 12th, 2020PR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced...
6y agoSOLYSoliton Appoints Dr. Michael Kaminer to Board of DirectorsPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Appoints Niquette Hunt to Board of DirectorsPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton to Present Poster on Pivotal Cellulite Data at Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual MeetingPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Selects Lippe Taylor Group as its Public Relations and Customer Engagement AgencyPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Appoints Greater Than One Group as its Integrated Marketing AgencyPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Announces Presentation at Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit 2020PR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Enters into Distribution Agreement with Aesthetic Solutions, Inc. for Initial Commercial Launch of its RAP DevicePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton to Present at the Cantor Virtual Global Healthcare ConferencePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Initiates New Tooling Production Process for Improved Cartridge in RAP DevicePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Announces Presentations at Masters in Aesthetics SymposiumPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Introduces Advanced Design for RAP CartridgesPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton, Inc.'s (SOLY) CEO Chris Capelli on Q2 2020 Results - Earnings Call TranscriptEarnings Call Transcripts
6y agoSOLYSoliton Reports Second Quarter 2020 ResultsPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported ...
6y agoSOLYSoliton Appoints Dr. Sachin Shridharani to Scientific Advisory BoardPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYNew patent application published for: Selective Laser Induced Optical Breakdown in Biological MediumUS Patent Applications (USPTO)
6y agoSOLYSoliton Announces Second Quarter 2020 Financial Results and Business Update on Tuesday, August 11, 2020PR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced...
6y agoSOLYSoliton Announces Presentation of Pivotal Cellulite Data at Virtual Music City Symposium for Cosmetic Advances & Laser Education (SCALE)PR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Provides Commercialization Update for Rapid Acoustic Pulse DevicePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Receives FDA Acceptance for 510(k) ApplicationPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th, 2020PR NewswireSoliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today ...
6y agoSOLYSoliton Files 510(k) with FDA for RAP Device for the Reduction of CellulitePR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...
6y agoSOLYSoliton Announces Pricing of Public OfferingPR NewswireSoliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today...